Acutus medical updates time and date of fourth quarter and full year 2021 financial results

Carlsbad, calif., march 17, 2022 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today updated the planned release of its fourth quarter and full year 2021 financial results to march 30, 2022, as the fiscal year end 2021 audit is not yet complete and is ongoing. there is no disagreement by management with the independent auditors, and the company fully expects to be in compliance with its sec filing requirements.
AFIB Ratings Summary
AFIB Quant Ranking